The OmniPod Insulin Management System: the latest innovation in insulin pump therapy

This review of insulin pump therapy focuses on the OmniPod® Insulin Management System (Insulet Corp., Bedford, MA, USA). The OmniPod System is the first commercially available “patch pump.” It is a fully integrated wearable pump, controlled wirelessly through a handheld device containing a built-in...

Descripción completa

Detalles Bibliográficos
Autor principal: Zisser, Howard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118276/
https://www.ncbi.nlm.nih.gov/pubmed/22127670
http://dx.doi.org/10.1007/s13300-010-0004-6
Descripción
Sumario:This review of insulin pump therapy focuses on the OmniPod® Insulin Management System (Insulet Corp., Bedford, MA, USA). The OmniPod System is the first commercially available “patch pump.” It is a fully integrated wearable pump, controlled wirelessly through a handheld device containing a built-in blood glucose meter. This is an evaluation of the OmniPod System, with the aim of providing an educational tool for physicians who are considering recommending this product to their patients. The review includes a discussion of the traditional insulin pump configuration and its limitations, a detailed overview of the OmniPod System, references to clinical study data, planned product enhancements, its use as an insulin delivery system in the Juvenile Diabetes Research Foundation’s Artificial Pancreas Project, and its use to deliver additional compounds.

Ejemplares similares